Company news
Venmax Drugs & Pharmaceuticals Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 24 2025
November 24, 2025
Announcement under Regulation 30 (LODR)-Resignation of Director
November 24, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 14 2025
November 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
November 14, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 12 2025
November 12, 2025
Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.
November 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting
November 12, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 05 2025
November 5, 2025
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended September 30, 2025.
November 5, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Oct 14 2025
October 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
October 14, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 29 2025
September 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
September 29, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 27 2025
September 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGM
September 27, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2025
September 26, 2025
Closure of Trading Window
September 26, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 03 2025
September 3, 2025
Board Meeting Outcome for Revised Outcome Of Board Meeting
September 3, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 02 2025
September 2, 2025
Reg. 34 (1) Annual Report.
September 2, 2025
Board Meeting Outcome for Outcome Of The Board Meeting
September 2, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 25 2025
August 25, 2025
Closure of Trading Window
August 25, 2025
Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
August 25, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 16 2025
August 16, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity Shares
August 16, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2025
August 8, 2025
Board Meeting Intimation for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Equity Share Warrants.
August 8, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 24 2025
July 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
July 24, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 23 2025
July 23, 2025
Financial Results For The Quarter Ended June 30, 2025.
July 23, 2025
Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2025.
July 23, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 16 2025
July 16, 2025
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2025.
July 16, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2025
July 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
July 14, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2025
June 27, 2025
Closure of Trading Window
June 27, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release May 10 2025
May 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
May 10, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release May 09 2025
May 9, 2025
Integrated Filing (Financial)
May 9, 2025
Audited Financial Results March 31St 2025.
May 9, 2025
Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31St, 2025.
May 9, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 26 2025
April 26, 2025
Change In Key Management
April 26, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 21 2025
April 21, 2025
Resignation Of Ms. Pratibha Jhawar From The Post Of Company Secretary & Compliance Officer
April 21, 2025